ĀÜĄņĀŅĀ×

Dennis McNamara, MD, is a Professor of Medicine and the Director of the Center for Heart Failure Research at the University of Pittsburgh Medical Center (UPMC). Dr. McNamara, a graduate of Yale University and Harvard Medical School, completed his research and clinical training at Massachusetts General Hospital in Boston before joining the University of Pittsburgh faculty in 1994.

For the last twenty years his research has focused on the pathogenesis of primary dilated cardiomyopathy and the impact of genetic heterogeneity on clinical outcomes. He directed the recently completed IPAC study (Investigation of Pregnancy Associated Cardiomyopathy), a thirty center investigation of myocardial recovery for women with peripartum cardiomyopathy.

He is a recognized leader in the field of pharmacogenomics and heart failure therapeutics, and his laboratory has functioned as a core genomics lab for numerous multiā€‘center trials including the AHeFT study of Heart Failure in African Americans. He is the Principal Investigator for the NIH funded multicenter investigation GRAHF2, (Genomic Response Analysis for Heart Failure Therapy in African Americans) which will explore the potential use of genomics to tailor heart failure therapeutics.